Cargando…

Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma

Detalles Bibliográficos
Autores principales: Ravanetti, Lara, Dekker, Tamara, Guo, Lihui, Dijkhuis, Annemiek, Dierdorp, Barbara S., Diamant, Zuzana, Florquin, Sandrine, Lutter, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087922/
https://www.ncbi.nlm.nih.gov/pubmed/36094742
http://dx.doi.org/10.1111/all.15513
_version_ 1785022459070644224
author Ravanetti, Lara
Dekker, Tamara
Guo, Lihui
Dijkhuis, Annemiek
Dierdorp, Barbara S.
Diamant, Zuzana
Florquin, Sandrine
Lutter, René
author_facet Ravanetti, Lara
Dekker, Tamara
Guo, Lihui
Dijkhuis, Annemiek
Dierdorp, Barbara S.
Diamant, Zuzana
Florquin, Sandrine
Lutter, René
author_sort Ravanetti, Lara
collection PubMed
description
format Online
Article
Text
id pubmed-10087922
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100879222023-04-12 Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma Ravanetti, Lara Dekker, Tamara Guo, Lihui Dijkhuis, Annemiek Dierdorp, Barbara S. Diamant, Zuzana Florquin, Sandrine Lutter, René Allergy Letters John Wiley and Sons Inc. 2022-09-18 2023-02 /pmc/articles/PMC10087922/ /pubmed/36094742 http://dx.doi.org/10.1111/all.15513 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Ravanetti, Lara
Dekker, Tamara
Guo, Lihui
Dijkhuis, Annemiek
Dierdorp, Barbara S.
Diamant, Zuzana
Florquin, Sandrine
Lutter, René
Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
title Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
title_full Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
title_fullStr Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
title_full_unstemmed Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
title_short Efficacy of FP‐025: A novel matrix metalloproteinase‐12 (MMP‐12) inhibitor in murine allergic asthma
title_sort efficacy of fp‐025: a novel matrix metalloproteinase‐12 (mmp‐12) inhibitor in murine allergic asthma
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087922/
https://www.ncbi.nlm.nih.gov/pubmed/36094742
http://dx.doi.org/10.1111/all.15513
work_keys_str_mv AT ravanettilara efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT dekkertamara efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT guolihui efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT dijkhuisannemiek efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT dierdorpbarbaras efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT diamantzuzana efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT florquinsandrine efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma
AT lutterrene efficacyoffp025anovelmatrixmetalloproteinase12mmp12inhibitorinmurineallergicasthma